Literature DB >> 11810557

A new model of pulmonary superinfection with Aspergillus fumigatus and Pseudomonas aeruginosa in mice.

M Yonezawa1, H Sugiyama, K Kizawa, R Hori, J Mitsuyama, H Araki, M Shimakura, S Minami, Y Watanabe, K Yamaguchi.   

Abstract

We have produced a new model of pulmonary super-infection with Aspergillus fumigatus and Pseudomonas aeruginosa in immunosuppressed mice. Male ICR mice were given an intratracheal inoculation of 4 x 10(5) conidia of A. fumigatus in agar beads, and were immunosuppressed with 100 mg/kg subcutaneous injections of cortisone acetate on days 7, 9, 12, 14, and 16 after inoculation. Twelve days after inoculation, with the agar beads, the mice were challenged with the intranasal instillation of 2 x 10(6) CFU of P. aeruginosa. The survival rates of superinfected, A. fumigatus-alone, P. aeruginosa-alone, and non-infected mice were 50%, 30%, 90%, and 100% 14 days after pseudomonal infection (26 days after inoculation of A. fumigatus), respectively. In the superinfected mice, both A. fumigatus and P. aeruginosa were detected more than 10 days after pseudomonal infection (22 days after inoculation of A. fumigatus). Histopathological examination revealed peribronchial necrosis around A. fumigatus hyphae and inflammation by P. aeruginosa. This infection model in mice would be useful for studying the pathogenesis of superinfection.

Entities:  

Mesh:

Year:  2000        PMID: 11810557     DOI: 10.1007/s101560070015

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  9 in total

1.  Pulmonary injury after combined exposures to low-dose low-LET radiation and fungal spores.

Authors:  B Marples; L Downing; K E Sawarynski; J N Finkelstein; J P Williams; A A Martinez; G D Wilson; M D Sims
Journal:  Radiat Res       Date:  2011-01-28       Impact factor: 2.841

Review 2.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

3.  Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.

Authors:  Alexandro Rodríguez-Rojas; María D Maciá; Alejandro Couce; Cristina Gómez; Alfredo Castañeda-García; Antonio Oliver; Jesús Blázquez
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

4.  Interkingdom metabolic transformations captured by microbial imaging mass spectrometry.

Authors:  Wilna J Moree; Vanessa V Phelan; Cheng-Hsuan Wu; Nuno Bandeira; Dale S Cornett; Brendan M Duggan; Pieter C Dorrestein
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

Review 5.  Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

Review 6.  Factoring in the Complexity of the Cystic Fibrosis Lung to Understand Aspergillus fumigatus and Pseudomonas aeruginosa Interactions.

Authors:  Emily Beswick; Jorge Amich; Sara Gago
Journal:  Pathogens       Date:  2020-08-06

7.  Biofilm Filtrates of Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients Inhibit Preformed Aspergillus fumigatus Biofilms via Apoptosis.

Authors:  Fazal Shirazi; Jose A G Ferreira; David A Stevens; Karl V Clemons; Dimitrios P Kontoyiannis
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

Review 8.  Let's Get Physical: Bacterial-Fungal Interactions and Their Consequences in Agriculture and Health.

Authors:  Breanne N Steffan; Nandhitha Venkatesh; Nancy P Keller
Journal:  J Fungi (Basel)       Date:  2020-10-23

9.  Exposure to the Pseudomonas aeruginosa secretome alters the proteome and secondary metabolite production of Aspergillus fumigatus.

Authors:  Anatte Margalit; David Sheehan; James C Carolan; Kevin Kavanagh
Journal:  Microbiology (Reading)       Date:  2022-03       Impact factor: 2.956

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.